LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 63 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76 | -53.4% | 51,628 | +1.0% | 0.00% | – |
Q2 2023 | $163 | -23.5% | 51,107 | -43.4% | 0.00% | – |
Q1 2023 | $213 | -47.9% | 90,313 | -23.3% | 0.00% | -100.0% |
Q4 2022 | $409 | -100.0% | 117,744 | -0.0% | 0.00% | 0.0% |
Q3 2022 | $863,000 | +20.5% | 117,792 | +7.3% | 0.00% | 0.0% |
Q2 2022 | $716,000 | +30.2% | 109,742 | +0.8% | 0.00% | 0.0% |
Q1 2022 | $550,000 | +409.3% | 108,904 | +683.3% | 0.00% | – |
Q4 2021 | $108,000 | -26.5% | 13,904 | +40.4% | 0.00% | – |
Q3 2021 | $147,000 | – | 9,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |